-
DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/d2a0ea/chronic_kidney_dis) has announced the addition of Global Markets Dire...
-
PHOENIX -- Billy Preston, the exuberant keyboardist who landed dream gigs with the Beatles and the Rolling Stones and enjoyed his own series of hit singles, including "Outta Space" and "Nothing From Nothing," died Tuesday at 59.
Preston's longtime manager, Joyce Moore, said Preston had been in a coma since November in a care facility and was taken to a hospital in Scottsdale on Saturday after his condition deteriorated.
-
DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/3b2fd1/dialysis_products) has announced the addition of the "Dialysis Produc...
-
In York County, a mother usually able to scrape by on her modest income is worried about making Christmas a happy occasion for her three children.
While money has always been tight, the family's financial situation has been more difficult since the birth of her youngest. Her toddler was born with chronic kidney failure. He has many medical appointments and the cost of gas to transport him is squeezing the household budget.
-
Business Editors/Health/Medical Writers
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 9, 2004
BMP-7 drug candidate, developed by Curis and licensed to O...
-
Fresenius Medical Care North American is a subsidiary of Fresenius Medical Care AG & Co., which is based in Germany and claims to be the world's largest integrated provider of products and services for people undergoing dialysis because of chronic kidney failure.
-
Business & Science Editors
CAMBRIDGE, Mass.--(BW HealthWire)--April 17, 2002
Curis, Inc. (NASDAQ: CRIS) - Findings published in the April issue of...
-
Orphan drug receives second approval for rare disease
SILVER SPRING, Md., Sept. 23, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Soliris (eculizumab) to treat patients with atypical Hemolytic Uremic Syndrome (aHUS), a rare and chronic blood disease that can lead to kidney (renal) failure and is also associated with increased risk of death and stroke.
-
Business Editors & Biotech-Industry Writers
LUCERNE, Switzerland--(BUSINESS WIRE)--June 11, 2001
Amgen (Nasdaq:AMGN) today announced that the Euro...
-
Renal Solutions Inc., a Cranberry-based developer of products that promise to dramatically improve the lifestyle of dialysis patients, is counting on its new corporate parent, Fresenius Medical Care AG & Co. KGaA of Germany, to fulfill its expectations for growth.
Fresenius, a global provider of products for individuals undergoing dialysis because of chronic kidney failure, on Thursday said it acquired Renal Solutions in a deal valued at up to $190 million.